| Company Name: |
VSK LIFE SCIENCES PRIVATE LIMITED
|
| Tel: |
+91 7995529789 |
| Email: |
info@vsklifesciences.com |
| Products Intro: |
Product Name:2-{4-[N-(5,6-diphenylpyrazin-2-yl)-N-isopropylamino]butyloxy}acetic acid tert-butyl ester
CAS:475084-96-9
Purity:98% Package:1 kg,5 kg, 10 kg,25kg and 1 MT
|
|
| | ( 2-{4-[N-(5,6-diphenylpyrazin-2-yl)-N-isopropylamino]butyloxy}acetic acid tert-butylester ) Basic information |
| Product Name: | ( 2-{4-[N-(5,6-diphenylpyrazin-2-yl)-N-isopropylamino]butyloxy}acetic acid tert-butylester ) | | Synonyms: | ( 2-{4-[N-(5,6-diphenylpyrazin-2-yl)-N-isopropylamino]butyloxy}acetic acid tert-butylester );4-[(5,6-diphenylpyrazin-2-yl)(isopropyl)amino]-1-butanol;[4-[(5,6-Diphenylpyrazinyl)(1-methylethyl)amino]butoxy]acetic acid 1,1-dimethylethyl ester;TUQMNTRUQSTQNJ-UHFFFAOYSA-N;Selexipag Impurity 8;tert-butyl 2-(4-((5,6-diphenylpyrazin-2-yl)(isopropyl)amino)butoxy)acetate;Acetic acid, 2-[4-[(5,6-diphenyl-2-pyrazinyl)(1-methylethyl)amino]butoxy]-, 1,1-dimethylethyl ester;1,1-Dimethylethyl 2-[4-[(5,6-diphenyl-2-pyrazinyl)(1-methylethyl)amino]butoxy]acetate | | CAS: | 475084-96-9 | | MF: | C29H37N3O3 | | MW: | 475.62 | | EINECS: | | | Product Categories: | | | Mol File: | 475084-96-9.mol | ![( 2-{4-[N-(5,6-diphenylpyrazin-2-yl)-N-isopropylamino]butyloxy}acetic acid tert-butylester ) Structure](CAS/20180702/GIF/475084-96-9.gif) |
| | ( 2-{4-[N-(5,6-diphenylpyrazin-2-yl)-N-isopropylamino]butyloxy}acetic acid tert-butylester ) Chemical Properties |
| Boiling point | 592.3±50.0 °C(Predicted) | | density | 1.090±0.06 g/cm3(Predicted) | | pka | 2.40±0.10(Predicted) |
| | ( 2-{4-[N-(5,6-diphenylpyrazin-2-yl)-N-isopropylamino]butyloxy}acetic acid tert-butylester ) Usage And Synthesis |
| Uses | 2-{4-[N-(5,6-Diphenylpyrazin-2-yl)-N-isopropylamino]butyloxy}acetic acid tert-butyl ester is an impurity of Selexipag (S253150), an orally available, highly selective, long-acting prostacyclin (IP) receptor agonist prodrug. It is a potential drug for the treatment of various vascular disorders such as pulmonary arterial hypertension and arteriosclerosis obliterans. |
| | ( 2-{4-[N-(5,6-diphenylpyrazin-2-yl)-N-isopropylamino]butyloxy}acetic acid tert-butylester ) Preparation Products And Raw materials |
|